MTOR and Insulin resistance: Despite these advances, the use of first- and second-generation mTOR inhibitors has been associated with a range of side effects such as insulin resistance, hyperglycemia, impaired wound healing, hypertension, and various metabolic, renal, and pulmonary complications.